US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Jun 1, 2026 (3 months ago)

Minocycline Hydrochloride Extended-Release Tablets, USP, 115 mg, 30-count bottle, Rx…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Dissolution Specifications: An out-of-specification (OOS) result was observed during the 9th month of dissolution test analysis

What was recalled

Minocycline Hydrochloride Extended-Release Tablets, USP, 115 mg, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA. Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054. NDC: 67877-644-30

Recalling firm
Ascend Laboratories, LLC
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0597-2026

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Chloride recalls

See all